Weibo Corp (ADR) (NASDAQ:WB) has gone through a roller-coaster of a rollicking ride in the few days since it started trading on April 17, 2014. But it now seems to have stabilized at around the $20 mark at which it ended the first day of trading. Weibo Corp (ADR) (NASDAQ:WB) shares after opening at $19.58 moved to $19.70 on last trade day and at the end of the day closed at $17.51 . Company price to sales ratio in past twelve months was calculated as 19.28. Weibo Corp (ADR) (NASDAQ:WB) showed a negative weekly performance of -22.56%.
Galena Biopharma Inc (NASDAQ:GALE) a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that the Company will report its first quarter financial results on Tuesday, May 6, 2014 after the close of the financial markets. The company will host a conference call following the announcement at 2:00 p.m. P.T./5:00 pm E.T. to discuss financial and business results. Galena Biopharma Inc (NASDAQ:GALE) shares advanced 4.37% in last trading session and ended the day on $2.39. GALE return on equity ratio is recorded as -435.40% and its return on assets is -113.60%. Galena Biopharma Inc (NASDAQ:GALE) yearly performance is -5.91%.
Canadian Solar Inc. (NASDAQ:CSIQ) one of the world’s largest solar power companies, announced that it has been awarded a module supply agreement to provide 43MW of photovoltaic (“PV”) modules to the second largest solar power plant project in Japan. Canadian Solar Inc. (NASDAQ:CSIQ) shares moved down -11.01% in last trading session and was closed at $26.83 while trading in range of $25.81 – $30.10. Canadian Solar Inc. (NASDAQ:CSIQ) year to date (YTD) performance is -10.03%.
Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) announced the appointment of E.J. Brandreth as Vice President of Quality. He will be responsible for all quality and compliance functions for a company that is moving forward with numerous late and early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He will report to Inovio’s Chief Operating Officer Dr. Niranjan Sardesai. Inovio Pharmaceuticals Inc (NYSEMKT:INO) weekly performance is -9.34%. On last trading day company shares ended up $2.33. Inovio Pharmaceuticals Inc (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is -27.15%. Analysts mean target price for the company is $5.00.
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) one of the world’s largest manufacturers of high-performance solar power products, announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2013 with the Securities and Exchange Commission of the United States. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) shares after opening at $10.70 moved to $10.73 on last trade day and at the end of the day closed at $9.53 . Company price to sales ratio in past twelve months was calculated as 0.40 and price to cash ratio as 1.34. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) showed a negative weekly performance of -9.32%.
Leave a Reply